Medifocus Announces Approach of 100,000 Prolieve(R) Treatments for Benign Prostatic Hyperplasia
News
Medifocus, Inc., a biotechnology company that uses heat-activation to treat diseases ranging from urological problems to breast cancer, recently announced that almost 100,000 men with Benign Prostatic Hyperplasia (BPH) have ... Read more